Polaryx Therapeutics, Inc. Common Stock

NASDAQ:PLYX

Biotechnology

Healthcare
$1.61 -0.87%

-$0.02 today

Market cap
$80.25M
Beta
0.00
P/E (TTM)
-16.7
EPS (TTM)
-$0.14
52W Low $2.01High $48.91

Volume 0.02M

Average 0.34M

Balance Sheet

Inspect the capital base behind the business.

Assets

$5.42M

FY 2025 · Annual

+8.4% YoY

Liabilities

$855,000.00

FY 2025 · Annual

+195.8% YoY

Equity

$4.57M

FY 2025 · Annual

-3.1% YoY

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$3.1M
Other Current$422.0K
Total Current Assets$3.5M
Total Assets$3.5M

Analysis

Selected assets total $3.5M for Latest. The largest visible component is Cash & Equivalents at $3.1M, about 87.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 12, 2026
8-KCurrent reportSep 14, 2026
8-KCurrent reportSep 1, 2026
10-QQuarterly reportAug 13, 2026
ARSARS filingJul 28, 2026

How much cash does PLYX have?

Polaryx Therapeutics, Inc. Common Stock (PLYX) reported $5.14M in cash and equivalents in fiscal 2025.

How much debt does PLYX carry?

Polaryx Therapeutics, Inc. Common Stock (PLYX) reported $0.00 of total debt, with net debt of -$5.14M.